Instil Bio, Inc. Banner Image

Instil Bio, Inc.

  • Ticker TIL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Instil Bio, Inc. Logo Image
  • 51-200 Employees
  • Based in Dallas, Texas
Instil Bio, Inc. (Nasdaq: TIL) is a clinical-stage biopharmaceutical company focused on developing TIL therapies for the treatment of patients with cancer. Instil has assembled an accomplished management team with a successful track record in the research, development and manufacture of cell therapies. Using its proprietary and optimized manufacturing processes at its in-house manufacturingMore facilities, Instil is developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStARâ„¢, platform, including ITIL-306, a next-generation, genetically-engineered TIL therapy using the CoStAR platform, for multiple solid tumors.
Instil Bio, Inc.

Most Recent Annual Report

Instil Bio, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Instil Bio, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!